Skip to main content

Cyclosporin

Volume 78: debated on Wednesday 1 May 1985

The text on this page has been created from Hansard archive content, it may contain typographical errors.

asked the Secretary of State for Social Services if he will estimate the costs per annum to the National Health Service of purchasing cyclosporin; if he will detail the current uses of this drug in the National Health Service; and if he will make a statement.

We do not usually give details of the sales of any drug as this information is regarded as confidential because of its commercial value. The current uses of cyclosporin include prevention of graft rejection following bone marrow, kidney, liver, pancreas, heart and heart-lung transplantation and prophylaxis of graft-versus-host disease.